These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 19924592)

  • 1. Acute maniform reaction to a single dose of escitalopram in a social phobic patient--an atypical jitteriness syndrome?
    Muhtz C; Agorastos A; Kellner M
    Pharmacopsychiatry; 2009 Nov; 42(6):291-2. PubMed ID: 19924592
    [No Abstract]   [Full Text] [Related]  

  • 2. [Efficacy and tolerability of escitalopram in anxiety disorders: a review].
    Pelissolo A
    Encephale; 2008 Sep; 34(4):400-8. PubMed ID: 18922243
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Eyelash Loss Secondary to Escitalopram But Not to Sertraline: A Case Report.
    Norton DJ; Cates C
    Prim Care Companion CNS Disord; 2016; 18(3):. PubMed ID: 27722027
    [No Abstract]   [Full Text] [Related]  

  • 4. Escitalopram in the treatment of social anxiety disorder: randomised, placebo-controlled, flexible-dosage study.
    Kasper S; Stein DJ; Loft H; Nil R
    Br J Psychiatry; 2005 Mar; 186():222-6. PubMed ID: 15738503
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Escitalopram for social anxiety disorder.
    Lele M; Joglekar A
    Br J Psychiatry; 2005 Sep; 187():290-1; author reply 291-2. PubMed ID: 16193620
    [No Abstract]   [Full Text] [Related]  

  • 6. Ondansetron-Induced Myoclonus With Escitalopram and HAART: Role of Drug Interactions.
    Kolli V; Addula M
    Prim Care Companion CNS Disord; 2019 Jul; 21(4):. PubMed ID: 31364825
    [No Abstract]   [Full Text] [Related]  

  • 7. Citalopram in social phobia.
    Kosieradzki PH
    J Am Acad Child Adolesc Psychiatry; 2001 Oct; 40(10):1126-7. PubMed ID: 11589525
    [No Abstract]   [Full Text] [Related]  

  • 8. An open-label trial of escitalopram in children and adolescents with social anxiety disorder.
    Isolan L; Pheula G; Salum GA; Oswald S; Rohde LA; Manfro GG
    J Child Adolesc Psychopharmacol; 2007 Dec; 17(6):751-60. PubMed ID: 18315447
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Escitalopram-Induced Rash.
    Prabhakar D; Sablaban I
    Prim Care Companion CNS Disord; 2019 Jan; 21(1):. PubMed ID: 30806996
    [No Abstract]   [Full Text] [Related]  

  • 10. Use of the selective serotonin reuptake inhibitor citalopram in the treatment of generalized social phobia.
    Bouwer C; Stein DJ
    J Affect Disord; 1998 Apr; 49(1):79-82. PubMed ID: 9574863
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [SSRI-induced akathesia].
    Hofmann M; Vidoni F
    Psychiatr Prax; 1996 May; 23(3):143-4. PubMed ID: 8711007
    [No Abstract]   [Full Text] [Related]  

  • 12. Selective serotonin re-uptake inhibitors (SSRIs) and alopecia areata.
    Ruiz-Doblado S; Carrizosa A; García-Hernández MJ; Rodríguez-Pichardo A
    Int J Dermatol; 1999 Oct; 38(10):798-9. PubMed ID: 10561061
    [No Abstract]   [Full Text] [Related]  

  • 13. Antidepressant-induced jitteriness/anxiety syndrome: systematic review.
    Sinclair LI; Christmas DM; Hood SD; Potokar JP; Robertson A; Isaac A; Srivastava S; Nutt DJ; Davies SJ
    Br J Psychiatry; 2009 Jun; 194(6):483-90. PubMed ID: 19478285
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Escitalopram in specific phobia: results of a placebo-controlled pilot trial.
    Alamy S; Wei Zhang ; Varia I; Davidson JR; Connor KM
    J Psychopharmacol; 2008 Mar; 22(2):157-61. PubMed ID: 18208904
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of citalopram and moclobemide in patients with social phobia: some preliminary findings.
    Atmaca M; Kuloglu M; Tezcan E; Unal A
    Hum Psychopharmacol; 2002 Dec; 17(8):401-5. PubMed ID: 12457375
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The efficacy of selective serotonin reuptake inhibitors in adult social anxiety disorder: a meta-analysis of double-blind, placebo-controlled trials.
    Hedges DW; Brown BL; Shwalb DA; Godfrey K; Larcher AM
    J Psychopharmacol; 2007 Jan; 21(1):102-11. PubMed ID: 16714326
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anxious depression and response to treatment.
    Nelson JC
    Am J Psychiatry; 2008 Mar; 165(3):297-9. PubMed ID: 18316424
    [No Abstract]   [Full Text] [Related]  

  • 18. Acute extrapyramidal syndrome induced by escitalopram: a case report.
    Nimber JS; Aggarwal A
    Psychopharmacology (Berl); 2014 Sep; 231(18):3813-4. PubMed ID: 25048289
    [No Abstract]   [Full Text] [Related]  

  • 19. Escitalopram in the treatment of generalized anxiety disorder: double-blind, placebo controlled, flexible-dose study.
    Davidson JR; Bose A; Korotzer A; Zheng H
    Depress Anxiety; 2004; 19(4):234-40. PubMed ID: 15274172
    [TBL] [Abstract][Full Text] [Related]  

  • 20. What is the threshold for symptomatic response and remission for major depressive disorder, panic disorder, social anxiety disorder, and generalized anxiety disorder?
    Bandelow B; Baldwin DS; Dolberg OT; Andersen HF; Stein DJ
    J Clin Psychiatry; 2006 Sep; 67(9):1428-34. PubMed ID: 17017830
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.